Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug save search
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.928 1.9K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -3.21%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.04%
TRUMY | $16.507 34K
|
Manufacturing
|
| O: 0.27%
H: 0.0%
C: -2.6%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.37%
H: 0.57%
C: 0.19%
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ABBV | News | $165.97 0.8% 3.1M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
drug patent report review global advanced market
Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers
Published: 2024-02-15 (Crawled : 15:00) - biospace.com/
LTRN | $5.45 -5.55% 130K
|
Health Technology
|
| O: -0.25%
H: 3.17%
C: -0.74%
pharma drug unique tumor program
Olezarsen receives Orphan Drug designation from U.S. FDA for familial chylomicronemia syndrome
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
IONS | $40.62 -0.47% 470K
|
Health Technology
|
| O: -1.53%
H: 3.16%
C: -6.29%
fda drug designation
United States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
Published: 2024-02-15 (Crawled : 01:00) - globenewswire.com
MESO | $5.17 1.17% 130K
|
Health Technology
|
| O: 1.04%
H: 5.13%
C: 4.87%
revascor drug disease children food designation heart grants
Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis
Published: 2024-02-14 (Crawled : 15:30) - biospace.com/
ATRA | $0.6782 -1.95% 880K
|
Health Technology
|
| O: 6.48%
H: 0.0%
C: -6.07%
ata3219 drug lupus treatment application submission
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Augtyro™ (repotrectinib) for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
Published: 2024-02-14 (Crawled : 15:00) - biospace.com/
BMY | $48.89 1.22% 5.1M
|
Health Technology
|
| O: 0.23%
H: 0.44%
C: 0.14%
drug review food tumors treatment application advanced
Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
Published: 2024-02-14 (Crawled : 14:00) - globenewswire.com
SILO | $2.01 2.03% 8.3K
|
Finance and Insurance
|
| O: -3.75%
H: 14.94%
C: 9.74%
sp-26 ketamine drug implant
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
Published: 2024-02-14 (Crawled : 11:00) - biospace.com/
STTK | $9.92 -2.07% 220K
|
Health Technology
|
| O: 2.48%
H: 4.38%
C: 3.46%
drug collaboration agreement
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
TNXP | $0.1592 1.4% 910K
|
Health Technology
|
| O: 1.81%
H: 0.88%
C: -6.29%
fda management drug fibromyalgia approval pharmaceuticals application submission
DLH to Provide Information Technology Services at National Institute on Drug Abuse
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
DLHC | $11.16 1.09% 24K
|
Commercial Services
|
| O: -0.12%
H: 0.15%
C: -1.58%
drug institute services technology
Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
JAGX | $0.1612 -8.98% 27M
|
Health Technology
|
| O: 6.09%
H: 7.88%
C: 0.68%
fda drug diarrhea health designation application crofelemer submission
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
Published: 2024-02-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
covid-19 sales drug
BMS, J&J and Merck CEOs Push Back in Senate Hearing on High Drug Prices
Published: 2024-02-09 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
drug back merck
Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell LymphomaCompany on track to initiate soquelitinib Phase 3 registrational clinical trial in PTCL
Published: 2024-02-08 (Crawled : 23:00) - biospace.com/
CRVS | $1.41 36K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.38%
drug granted cell treatment pharmaceuticals designation trial
Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
CRVS | $1.41 36K
|
Health Technology
|
| O: 9.0%
H: 18.35%
C: 1.61%
drug granted cell treatment pharmaceuticals designation
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
AMRX | $5.37 0.19% 500K
|
Health Technology
|
| O: 0.18%
H: 1.83%
C: 1.83%
ipx203 drug resubmission application response
J&J Lawsuit Asserts Employer Liability for High Drug Costs
Published: 2024-02-08 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
drug
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
Published: 2024-02-07 (Crawled : 14:30) - globenewswire.com
IMMX | News | $2.225 0.68% 38K
|
|
| O: -2.83%
H: 11.64%
C: 10.18%
nxc-201 drug biopharma designation
Johnson & Johnson Celebrates Innovation in Novel Drug Delivery Systems with 2023 Dr. Paul Janssen Award
Published: 2024-02-07 (Crawled : 13:30) - prnewswire.com
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: 0.0%
award drug innovation
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published: 2024-02-07 (Crawled : 09:00) - prnewswire.com
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
INCY | $52.07 -1.42% 800K
|
Health Technology
|
| O: -0.65%
H: 0.57%
C: -3.21%
first management drug application china
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.